Richard Elion

Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services

Albert Liu, Stephanie E. Cohen, Eric Vittinghoff et al. · JAMA Internal Medicine · 2015 · 622 citations · Full text

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

Mark Sulkowski, Joseph J. Eron, David Wyles et al. · JAMA · 2015 · 305 citations · Full text

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Anthony Mills, José Ramón Arribas, Jaime Andrade‐Villanueva et al. · The Lancet Infectious Diseases · 2015 · 304 citations

Hiv/aids Counselling, Treatment And Prevention, Pharmacology +11

Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients

Edwin DeJesus, Daniel Berger, Martin Markowitz et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 268 citations

Weight Loss as a Predictor of Survival and Disease Progression in HIV Infection

David A. Wheeler, Cynthia L. Gibert, Cynthia A. Launer et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1998 · 234 citations

Disease Progression, Weight Management, Mild Weight Loss +18